WOOF
Petco Health and Wellness Company, Inc.
NasdaqGSUSDEQUITY
Consumer Cyclical
DELAYED
Last price
2.80
▼ 0.05 (1.75%)
MARKET · —
Price
Open
2.85
Prev close
2.85
Day high
2.87
Day low
2.82
Volume
986.85K
Market cap
$811.01M
P/E (TTM)
142.00
52W range
2.24 – 4.19
Trailing performance
Returnvs SPY
1W
+0.71%
+2.1%
1M
+11.81%
+8.1%
3M
+7.17%
+4.1%
6M
+10.94%
-0.1%
YTD
+1.07%
-11.2%
1Y
-16.22%
-36.2%
3Y
-58.48%
-132.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$811.01M
Enterprise value$3.43B
Revenue (TTM)$5.96B
Gross profit$2.31B
EBITDA$326.54M
Net income$5.58M
EPS (TTM)$0.02
Free cash flow$121.46M
Total cash$166.97M
Total debt$2.78B
Book value / share$4.14
Shares outstanding247.77M
Float90.60M
Short % of float20.97%
Dividend yield—
Beta (5Y)1.54
Valuation & profitability ratios
Trailing P/E142.00
Forward P/E10.22
PEG ratio—
Price / sales—
Price / book0.69
EV / revenue0.58
EV / EBITDA10.50
Gross margin38.72%
Operating margin1.64%
Profit margin0.09%
Return on equity0.49%
Return on assets1.60%
Debt / equity241.06
Current ratio0.85
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Total revenue | $5.96B | $6.12B | $6.26B | $6.04B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $9.07M | -$101.82M | -$1.28B | $90.80M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net income | $9.07M | -$101.82M | -$1.28B | $90.80M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Apr 2026 | 0.03 | 0.03 | -12.7% |
| Jan 2026 | 0.04 | 0.04 | +8.7% |
| Oct 2025 | 0.02 | 0.04 | +73.9% |
| Jul 2025 | 0.02 | 0.07 | +217.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.07 | 8 | $1.49B | +0.3% |
| Next quarter | 0.06 | 8 | $1.48B | +1.0% |
| Current year | 0.22 | 8 | $6.00B | +0.6% |
| Next year | 0.28 | 8 | $6.09B | +1.5% |
Analyst targets & ownership
Mean target$3.54
High target$5.00
Low target$2.34
Implied upside26.56%
Analyst count11
ConsensusHOLD
Strong buy / Buy1 / 1
Hold8
Sell / Strong sell0 / 2
Held by insiders3.42%
Held by institutions121.97%
Institutions holding266
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
-187.05K
Net selling
Buy transactions
7
364.98K shares
Sell transactions
3
552.03K shares
Net transactions
+10
Buys less sells
Sell : buy shares
1.5 : 1
Mixed
Insider-held shares
9.76M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 9, 26 | MAY HOLLY Officer |
SELL | 200.00K | $508.00K | Direct |
| Jul 8, 26 | MAY HOLLY Officer |
SELL | 250.00K | $637.50K | Direct |
| Jun 30, 26 | YEN IRIS Director |
STOCK | 60.66K | $0 | Direct |
| Jun 30, 26 | BRIGGS GARY S Director |
STOCK | 60.66K | $0 | Direct |
| Jun 30, 26 | MOHAN RAJENDRA MICHAEL Director |
STOCK | 60.66K | $0 | Direct |
| Jun 30, 26 | BREITNER CAMERON Director |
STOCK | 60.66K | $0 | Direct |
| Jun 30, 26 | MURPHY GLENN K Director |
STOCK | 60.66K | $0 | Direct |
| May 1, 26 | ANDERSON JOEL D. Chief Executive Officer |
STOCK | 2.86K | $7.01K | Direct |
| Mar 13, 26 | VENEZIA PATRICK JOSEPH Officer |
SELL | 102.03K | $349.07K | Direct |
| Mar 13, 26 | VENEZIA PATRICK JOSEPH Officer |
CONVERSION | 58.80K | $144.66K | Direct |
| Jan 30, 26 | ANDERSON JOEL D. Chief Executive Officer |
STOCK | 5.00K | $11.45K | Direct |
| Dec 1, 25 | VENEZIA PATRICK JOSEPH Officer |
SELL | 74.19K | $228.51K | Direct |
| Aug 1, 25 | ANDERSON JOEL D. Chief Executive Officer |
STOCK | 1.10K | $2.73K | Direct |
| Jul 24, 25 | YEN IRIS Director |
STOCK | 43.42K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANDERSON JOEL D. |
Chief Executive Officer | 4.81M | Stock Award(Grant) |
BREITNER CAMERON |
Director | 903.34K | Stock Award(Grant) |
BRIGGS GARY S |
Director | 223.42K | Stock Award(Grant) |
INSANA GIOVANNI |
Officer | 522.43K | Stock Award(Grant) |
MAY HOLLY |
Officer | 1.33M | Sale |
MOHAN RAJENDRA MICHAEL |
Director | 583.69K | Stock Award(Grant) |
MURPHY GLENN K |
Director | 2.53M | Stock Award(Grant) |
ROMANKO MICHAEL |
Officer | 1.32M | Stock Award(Grant) |
SIMMONS SABRINA LOUISE |
Chief Financial Officer | 1.52M | Stock Award(Grant) |
VENEZIA PATRICK JOSEPH |
Officer | 398.83K | Sale |
Moving averages & technicals
SMA 10
2.79
+0.25% from price
SMA 20
2.81
+1.09% from price
SMA 50
2.71
+4.92% from price
SMA 100
2.75
+1.68% from price
SMA 200
2.81
+1.15% from price
EMA 12
2.81
-0.40% from price
EMA 26
2.78
+0.86% from price
EMA 50
2.75
+1.73% from price
RSI (14)
53.5
Neutral
MACD (12,26,9)
0.04
Hist 0.00
ATR (14)
0.13
4.49% of price
Realised vol 30D
48.1%
Annualised
Bollinger upper
2.97
20, 2σ
Bollinger lower
2.65
20, 2σ
50 / 200 cross
Death
2.71 vs 2.81
Trend bias
Above 200
+1.15%
Risk profile
Beta vs SPY
0.84
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
48.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-41.6%
Peak to trough
Max drawdown 5Y
-94.2%
Peak to trough
ATR 14
0.13
4.49% of price
Beta (reported)
1.54
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.35
Call-heavy session
Put / call open interest
0.20
Positioning, not flow
Max pain
3.00
+5.6% from spot
ATM implied vol
76.6%
Nearest strike to spot
Skew (10% OTM)
+2.3%
Puts bid over calls
Call volume
215
Contracts, this expiry
Put volume
75
Contracts, this expiry
Heaviest call OI
3.00
2.99K contracts
Heaviest put OI
3.00
797 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
3 Consumer Stocks We Find Risky
StockStory · 1d ago
Arhaus, Inc. (ARHS) Q2 Earnings and Revenues Top Estimates
Zacks · 16d ago
Petco Appoints Jeffrey Naylor to Board of Directors
PR Newswire · 19d ago
1 Cash-Producing Stock Worth Investigating and 2 We Ignore
StockStory · 22d ago
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Ignore
StockStory · 26d ago
Chewy vs. Petco Health and Wellness: E-commerce Growth vs. Omnichannel Stability
Motley Fool · 30d ago
Petco Shares Ease After HR Chief Sells $508,000 Worth of Stock (WOOF)
InvestorsHub · 40d ago
3 Reasons to Avoid WOOF and 1 Stock to Buy Instead
StockStory · 45d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.